Black HFrEF Patients Fare Better With Empagliflozin Black HFrEF Patients Fare Better With Empagliflozin

Empagliflozin trial data from patients with heart failure with reduced ejection fraction signal more benefit in Black compared with White patients.MDedge News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news